Literature DB >> 3619898

N-terminal amino acid sequence of two novel tumor-derived adenylate cyclase-stimulating proteins: identification of parathyroid hormone-like and parathyroid hormone-unlike domains.

A F Stewart, T Wu, D Goumas, W J Burtis, A E Broadus.   

Abstract

A 17,000 dalton human adenylate cyclase-stimulating protein has previously been purified from a human tumor associated with humoral hypercalcemia of malignancy. This report describes the purification of a related 7,000-9,000 MW protein from a second tumor, and provides N-terminal amino acid sequence of these two peptides. The sequences of the peptides are identical, defining the smaller peptide as an N-terminal portion of the larger peptide. The two peptides possess one region of strong homology with parathyroid hormone and a second divergent region. These structural similarities and differences may explain the similarities and differences which occur in patients with hyperparathyroidism and humoral hypercalcemia of malignancy.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3619898     DOI: 10.1016/0006-291x(87)90581-x

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  33 in total

1.  Parathyroid Hormone-related Protein in Breast Cancer Tissues: Relationship between Primary and Metastatic Sites.

Authors: 
Journal:  Breast Cancer       Date:  1994-07-30       Impact factor: 4.239

2.  Prediction of the tertiary structure of parathyroid-hormone-related protein (residues 1-34) by the island model.

Authors:  M Ota; N Saitô
Journal:  J Protein Chem       Date:  1992-12

3.  Identification of a cDNA encoding a parathyroid hormone-like peptide from a human tumor associated with humoral hypercalcemia of malignancy.

Authors:  M Mangin; A C Webb; B E Dreyer; J T Posillico; K Ikeda; E C Weir; A F Stewart; N H Bander; L Milstone; D E Barton
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

Review 4.  Incidence and pathophysiology of hypercalcemia.

Authors:  G R Mundy
Journal:  Calcif Tissue Int       Date:  1990       Impact factor: 4.333

5.  Heterogeneity in hormone responses and patterns of collagen synthesis in cloned dermal fibroblasts.

Authors:  S R Goldring; M L Stephenson; E Downie; S M Krane; J H Korn
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

6.  High levels of a parathyroid hormone-like protein in milk.

Authors:  A A Budayr; B P Halloran; J C King; D Diep; R A Nissenson; G J Strewler
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

7.  Age-related decrease in the effect of parathyroid hormone-related protein on cytosolic free calcium level and tension in rat aortic smooth muscle.

Authors:  M Ishikawa; Y Ouchi; M Akishita; K Kozaki; K Toba; A Namiki; T Yamaguchi; H Ito; H Orimo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-05       Impact factor: 3.000

Review 8.  Hypercalcaemia of malignancy.

Authors:  P J Kelly; J A Eisman
Journal:  Cancer Metastasis Rev       Date:  1989-06       Impact factor: 9.264

Review 9.  Drugs used in the treatment of metabolic bone disease. Clinical pharmacology and therapeutic use.

Authors:  S Patel; A R Lyons; D J Hosking
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

Review 10.  Hypercalcemia in malignancy.

Authors:  G J Strewler; R A Nissenson
Journal:  West J Med       Date:  1990-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.